吉利德科學：醜陋財報數據背後隱藏的強勁季度表現 (NASDAQ:GILD)
· seekingalpha.com
吉利德科學（Gilead Sciences）在 2026 年第二季後被上調至「審慎買進」評級，主因是強勁的營收成長及調升的全年財務指引。點擊此處閱讀更多關於 GILD 股票的資訊。
Gilead Sciences, Inc. ( GILD ) is one of my long‑term holdings, and it actually took several years before this investment paid off. In the last few years, I w...